Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Hematology/Oncology Clinics of North America|June 24, 2019
Overview of Cutaneous T-Cell LymphomasCecilia A Larocca, Nicole R LeBoeufFrontiers in Oncology|January 30, 2023
Harnessing the immune system in the treatment of cutaneous T cell lymphomasChristopher J Fay, Katherine C Awh, Nicole R LeBoeuf, et al.American Journal of Clinical Dermatology|August 9, 2020
An Update on the Role of Talimogene Laherparepvec (T-VEC) in the Treatment of Melanoma: Best Practices and Future DirectionsCecilia A Larocca, Nicole R LeBoeuf, Ann W Silk, et al.American Journal of Clinical Dermatology|July 3, 2023
Diagnosis and Management of Dermatologic Adverse Events from Systemic Melanoma TherapiesChristopher J Fay, Samantha Jakuboski, Beth Mclellan, et al.Clinical Rheumatology|June 29, 2011
Schnitzler's syndrome associated with pancreatitis: a disease of IL-1 dysregulationCecilia A Larocca, John W McEvoy, Carla L Ellis, et al.The Journal of Investigative Dermatology|May 24, 2013
Selective inhibition of p300 HAT blocks cell cycle progression, induces cellular senescence, and inhibits the DNA damage response in melanoma cellsGai Yan, Mark S Eller, Courtney Elm, et al.The American Journal of Surgical Pathology|April 20, 2026
The Clinicopathologic and Genomic Features of Mature Versus Blastic Plasmacytoid Dendritic Cell Neoplasms Arising From Chronic Myeloid NeoplasmsSarah J Wu, Christopher B Hergott, Gabriel K Griffin, et al.Pageof 1